Haru Morita
Fondateur chez MODALIS THERAPEUTICS CORPORATION
Fortune : 3 M $ au 30/04/2024
Postes actifs de Haru Morita
Sociétés | Poste | Début | Fin |
---|---|---|---|
MODALIS THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | 01/01/2016 | - |
Directeur Général | 01/01/2016 | - | |
Fondateur | 01/01/2016 | - | |
President | 01/01/2016 | - | |
Modalis Therapeutics, Inc. | Directeur Général | 01/04/2016 | - |
Historique de carrière de Haru Morita
Anciens postes connus de Haru Morita
Sociétés | Poste | Début | Fin |
---|---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Directeur Général | 01/03/2006 | - |
Président | 01/03/2006 | - | |
Fondateur | 01/03/2006 | - | |
President | 01/03/2006 | - | |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Corporate Officer/Principal | - | - |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Directeur Technique/Scientifique/R&D | 15/07/2009 | - |
Corporate Officer/Principal | - | 15/07/2009 | |
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Corporate Officer/Principal | - | - |
Formation de Haru Morita
School of Engineering, The University of Tokyo | Graduate Degree |
Statistiques
Internationale
Japon | 5 |
Etats-Unis | 3 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Founder | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MODALIS THERAPEUTICS CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Health Technology |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Commercial Services |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Modalis Therapeutics, Inc. |
- Bourse
- Insiders
- Haru Morita
- Expérience